Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia

NCT04466007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Limb Ischemia
Diabetic Foot

Interventions

DRUG: High dose allogeneic mesenchymal stromal cells
DRUG: Low dose allogeneic mesenchymal stromal cells
DRUG: Placebos

Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]